123 related articles for article (PubMed ID: 2906459)
21. Roxatidine, an H(2) receptor blocker, is an estrogenic compound--experimental evidence.
Agrawal SS; Alvin Jose M
Syst Biol Reprod Med; 2010 Aug; 56(4):286-91. PubMed ID: 20718616
[TBL] [Abstract][Full Text] [Related]
22. Structural requirements for roxatidine in the stimulant effect of rat gastric mucin synthesis and the participation of nitric oxide in this mechanism.
Ichikawa T; Ishihara K; Saigenji K; Hotta K
Br J Pharmacol; 1997 Nov; 122(6):1230-6. PubMed ID: 9401791
[TBL] [Abstract][Full Text] [Related]
23. Roxatidine in duodenal ulcer.
Habibullah CM; Habeeb MA; Singh SP
J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
[TBL] [Abstract][Full Text] [Related]
24. Twenty-four-hour intragastric acidity following early evening or bedtime administration of roxatidine in duodenal ulcer patients.
Lazzaroni M; Sangaletti O; Bargiggia S; Bensi G; Canali A; Bianchi Porro G
Aliment Pharmacol Ther; 1996 Apr; 10(2):187-91. PubMed ID: 8730248
[TBL] [Abstract][Full Text] [Related]
25. Effects of combined use of roxatidine and pirenzepine on gastric secretion in humans.
Misawa T; Chijiiwa Y; Yoshida K; Tanaka A; Kabemura T; Fujishima H; Harada N; Nawata H
Fukuoka Igaku Zasshi; 1990 Jul; 81(7):242-6. PubMed ID: 1976580
[TBL] [Abstract][Full Text] [Related]
26. New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer.
Amarapurkar DN; Parikh SS; Desai HG
J Assoc Physicians India; 1993 Aug; 41(8):496-7. PubMed ID: 7904993
[TBL] [Abstract][Full Text] [Related]
27. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
Okabe S; Takagi K; Igata H; Kato S; Shimosako K; Yamaji Y; Seiki M
Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
[TBL] [Abstract][Full Text] [Related]
28. [Effects of the histamine H2 receptor antagonist roxatidine acetate on stomach and liver alcohol dehydrogenase and serum alcohol level].
Beil W; Sewing KF
Z Gastroenterol; 1993 Nov; 31(11):643-5. PubMed ID: 7904786
[TBL] [Abstract][Full Text] [Related]
29. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic approach in patients with concomitant disease/drug--drug interactions (roxatidine acetate).
Collins JD
Scand J Gastroenterol Suppl; 1988; 146():89-99. PubMed ID: 2906472
[TBL] [Abstract][Full Text] [Related]
31. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study Group.
Gilinsky NH; Bright-Asare P; Cobert BL; Fitch DD; Lanza FL; Kerr RM; Savitsky JP
Am J Gastroenterol; 1992 Jul; 87(7):847-53. PubMed ID: 1352083
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of a single 24-hour pre-anesthetic dose of proton pump inhibitors.
Hirota K; Imai A; Kudo M; Hashimoto H; Kushikata T
J Gastroenterol Hepatol; 2009 Jul; 24(7):1244-7. PubMed ID: 19486452
[TBL] [Abstract][Full Text] [Related]
33. [Clinical evaluation of roxatidine acetate hydrochloride injection as preanesthetic medication].
Kawanishi M; Enomoto A; Shimada Y; Kurokawa Y
Masui; 1991 Sep; 40(9):1364-70. PubMed ID: 1682516
[TBL] [Abstract][Full Text] [Related]
34. Chemical and biologic characteristics of roxatidine acetate.
Bickel M; Herling AW; Schoelkens B; Scholtholt J
Scand J Gastroenterol Suppl; 1988; 146():78-88. PubMed ID: 2906471
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
Lin JH
Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
[TBL] [Abstract][Full Text] [Related]
36. A histamine H2 receptor antagonist, roxatidine, stimulates mucus secretion and synthesis by cultured rabbit gastric mucosal cells.
Takahashi S; Okabe S
J Physiol Pharmacol; 1995 Dec; 46(4):503-11. PubMed ID: 8770793
[TBL] [Abstract][Full Text] [Related]
37. Assessment of intragastric acidity in man: modern aspects, reproducibility of intragastric pH-monitoring, and pharmacodynamic results obtained with H2-receptor antagonists.
Merki HS; Witzel L; Kaufmann D; Kempf M; Muessig V; Neumann J; Scheurle E; Roehmel J; Walt RP
Scand J Gastroenterol Suppl; 1988; 146():142-52. PubMed ID: 2906458
[TBL] [Abstract][Full Text] [Related]
38. Cytoprotective action of roxatidine acetate HCl.
Shiratsuchi K; Fuse H; Hagiwara M; Mikami T; Miyasaka K; Sakuma H
Arch Int Pharmacodyn Ther; 1988; 294():295-304. PubMed ID: 2906796
[TBL] [Abstract][Full Text] [Related]
39. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
[TBL] [Abstract][Full Text] [Related]
40. [Circadian aspects of diclofenac gastroduodenopathy and the protective effect of roxatidine].
Müller P; Jackisch P; Simon B
Z Rheumatol; 1993; 52(5):297-300. PubMed ID: 7903132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
